Director, Manufacturing Operations
Vice President, Operations and Client Services
Vice President, Quality Assurance
Director, Formulation Sciences
Director, Drug Delivery Technologies
Director, Drug Eluting Device Development
Director, Analytic Services
Director, Project Management
Dr. Lee is responsible for product and business development along with providing strategic direction. Before joining LLS Health, Rob held senior management positions at Novavax, Inc., Lyotropic Therapeutics, Inc., and Imcor Pharmaceutical Co. He holds BSs in Biology and Chemistry from the University of Washington and a PhD in Physical Bioorganic Chemistry from the University of California, Santa Barbara. Rob has published more than three dozen articles and five book chapters plus holds 11 issued patents and 15 provisional or PCT patent applications. He has over 30 years of experience in pharmaceutical research and development of both therapeutic drugs and diagnostic imaging agents. Rob maintains strong academic ties, including an appointment as Adjunct Associate Professor of Pharmaceutical Chemistry at the University of Kansas in the early 1990s, serving as a reviewer for both the International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences, and serving on the Editorial Board for the Journal MOJ Bioequivalence & Bioavailability, The Scientific Pages of Nanotechnology, and The Journal of Analytical and Pharmaceutical Research.
Dr. Morgan has worked with LLS Health, a Lubrizol Life Science Company, since 2014 and was named as General Manager in 2018. In addition, Dr. Morgan has a larger global role serving as the Global Business Director for all of Lubrizol Life Science’s Pharmaceutical businesses, facilitating a strong relationship between the different business units. Prior to these roles, she served as Senior Business Development Manager, leading mergers and acquisitions and partnership initiatives for the Life Science’s group, and Global Market Manager for the ophthalmic market segment across the medical device and pharmaceutical business units. Dr. Morgan received her B.A. in Chemistry from Kenyon College and her Ph.D. in Organic Chemistry from the University of Pennsylvania. Prior to joining LLS Health, Barbara had over 10 years’ experience in both drug development and business development in the pharmaceutical industry. She has published numerous articles in peer-reviewed journals and holds patents, including one on the treatment of cancer stem cells.
James S. Drob joined LLS Health in 2020 as Director of Manufacturing Operations. James has been a leader in production and continuous improvement for his entire career, including over 14 years at pharmaceutical companies (Sanofi-Pasteur, Akorn Pharmaceuticals, and ForDoz Pharma). In these positions, James has been a proven leader; developing team members potentials, and championing efforts to establish new cGMP programs improving both the efficiency and robustness of existing teams and sterile drug product manufacturing lines. He is considered a Subject Matter Expert (SME) in aseptic processing, sterile manufacturing, and sterile injectables, including validation of aseptic processes and equipment. James has experience leading teams through successful inspections and Pre-Approval Inspections (PAIs) from the FDA as well as multiple international agencies including the EU. He has introduced new technologies, processes, and equipment to aseptic formulation, filling, and packaging lines. He graduated with high honors in his Master’s degree in Public Administration (MPA) and Summa Cum Laude in his Bachelor’s degree (BS) in Health Services Administration from Marywood University.
Dr. Frank has been leading Project Management, Product Development and Client Relations at LLS Health since 2007. His scientific background is in Organic Chemistry, with 30 years of experience leading Discovery Chemistry and Project Management efforts in both large publicly traded companies and small biotechnology firms. Prior to joining LLS Health, Bruce was Director of Discovery Chemistry at FMC Corporation (Princeton, NJ) where he directed over 40 medicinal and analytical chemistry scientists on site and overseas. Previous positions include Director of Chemistry at Kimeragen/Valigen (Newtown, PA), Senior Scientist at Hybridon (Cambridge, MA) and Post-doctoral Scientist at DuPont-Merck Pharmaceutical Co. (Wilmington, DE). He received his PhD in Organic Chemistry from the University of Maryland, College Park, and a BA in Chemistry from Temple University. Bruce has over 45 publications, presentations and patent disclosures to his credit.
Judith Cohen joined LLS Health in 2013 as Associate Director, Quality Assurance. Prior to joining LLS Health, Judith held leadership roles for over 22 years at Johnson & Johnson within the Pharmaceutical and Medical Device Sectors. She has extensive experience developing and implementing quality systems to support the manufacture and analytical characterization of clinical trial materials and commercial product. Judith has been integral in the preparation of Chemistry & Manufacturing Control sections for regulatory submissions worldwide for both pharmaceutical and drug/device combination products leading to the commercialization of over 20 products. Judith earned her Bachelor of Science in Chemistry from the University of Delaware and is a Fellow of the American Chemical Society.
Mr. Gwozdz joined LLS Health in 1994 to establish and run the formulations laboratory. Prior to that, he spent 13 years working in the specialty ink industry. He is now responsible for managing the Formulation Services group, encompassing multiple delivery vehicle formats, such as topical, vaginal, buccal, nasal, and injectables, as well as techniques related to fine particle dispersion, suspension, and size reduction. He has developed and scaled a number of commercialized formulations as well as many to support preclinical and clinical research. Mr. Gwozdz holds patents relating to drug delivery, as well as encapsulation and particulate surface modification technologies. He earned his Bachelor’s of Science in Chemistry from the University of Pittsburgh.
Kim joined LLS Health in 2012, bringing her expertise in drug delivery and biomaterials to the Formulation Services group. She now aids in leading the development, scale-up and manufacturing of a broad spectrum of drug products at LLS health. Kim received her PhD in Biomedical Engineering from Boston University under an NIH training grant in Qualitative Biology and Physiology, where her work focused on biodegradable polymer synthesis and micro- and nano-particulates for targeted and controlled release of chemotherapeutics. She also holds a BS from Lehigh University in Chemical Engineering.
Jite Okoh joined LLS Health in 2010 as a Formulation Scientist and subject matter expert in the development and fabrication of drug eluting devices. Prior to joining LLS health, Jite worked for various pharmaceutical and medical device companies including DSM Nutritional Products and Teleflex Medical (Arrow International) where he obtained extensive experiences in the incorporation of pharmaceutical actives into numerous polymeric medical devices. He leads a team of formulators, with diverse backgrounds, responsible for the research, development and clinical scale up of drug and device combination products. Jite holds several patents and has co-authored technical publications relating to drug delivery devices. He earned his Bachelor’s of Science in Chemistry from Kutztown University.
Laurie Goldman joined LLS Health in 1997 as Analytic and Quality Manager. Building on a solid quality control and quality assurance framework from previous experience in the electronic chemicals, mining, and inks/coatings industries, she established and grew the state-of-the-art analytical laboratory at LLS Health. She has co-authored numerous technical publications. She holds a B.S. in Chemistry from Muhlenberg College and has been certified in statistical process control, quality engineering, and quality auditing. At LLS Health, she has overseen the development and validation of hundreds of analytical methods used for clinical intermediate and finished pharmaceutical products.
Joey has served as Marketing Director of LLS Health’s CDMO Division since 2017 and has been involved in pharmaceutical new business development since 2013. Prior to joining the CDMO division, she spent nearly 15 years in marketing roles in various Lubrizol business units. Joey also has over 10 years of experience in finance at Lubrizol, Ford Motor Company, and The Franklin Mint. She received Bachelor of Science degrees in Finance and Accounting from Juniata College and her M.B.A from the Smeal College of Business at Pennsylvania State University.
Jenn joined the Project Management group of LLS Health, CDMO Division in 2014. Prior to that, she spent 12 years working at Merck in Safety Assessment within the Merck Research Labs Division where she led non-GLP and GLP animal studies. Jenn now oversees the Project Management group. Her group is responsible for overseeing all projects within LLS Health CDMO Division and specializes in directing Client projects with aggressive GMP timelines. Jenn received her Bachelor of Science in Small Animal Science and Conservation from Delaware Valley University and her Master of Business with Management Concentration from DeSales University.